AzTrials
AzTrials

Research institution

Georgetown University Clinical Trials

Studies where Georgetown University is the lead sponsor: what is enrolling now, by phase, condition and country.

291 registered studies

Search and filter these trials

In numbers

Open to volunteers
37
Active
54
With results posted
82
All registered
291

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 37

  • Insomnia

    Assessing the Feasibility of Web-based Insomnia Treatment Among Prostate Cancer Survivors

    • Recruiting
    • Age: 21 years and older
    • Lifestyle or therapy programme

    This pilot study will recruit Black/African American prostate cancer survivors into a clinical trial and will randomize each person to 1 of 2 possible treatments - an internet-based treatment for insomnia called Sleep Healthy…

    Trial name
    SIESTA-P (NCT07128927)
    Testing
    Sleep Healthy Using the Internet (SHUTi), Patient education
    Where
    United States
    Volunteers
    40 people
    Sponsor
    Georgetown University
    Can I take part? SIESTA-P

  • Non-small Cell Lung Cancer Stage III

    Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

    • Recruiting
    • Age: 18 years and older
    • Phase 2
    • Injection or infusion

    The goal of this clinical trial is to learn about neoadjuvant cemiplimab with histology-specific chemotherapy followed by resection and adjuvant cemiplimab in stage 3 non-small cell lung cancer (NSCLC) with select N3 lymph node…

    Trial name
    NEO-SURG (NCT06449313)
    Testing
    Cemiplimab-Rwlc
    Where
    3 sites in United States
    Volunteers
    21 people
    Sponsor
    Georgetown University
    Can I take part? NEO-SURG

  • Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

    RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 2
    • Surgery or procedure

    This is a prospective, interventional, non-randomized, phase 2 study to assess oncologic outcomes of metastatic hormone-sensitive prostate cancer (mCSPC) patients who receive a risk-adapted treatment approach followed by…

    Trial name
    RISK-ADAPT (NCT07645326)
    Testing
    Androgen Deprivation Therapy (ADT), Androgen Receptor Pathway Inhibitor (ARPI), Prostate Radiation
    Where
    United States
    Volunteers
    108 people
    Sponsor
    Georgetown University
    Can I take part? RISK-ADAPT

  • Spinal Stenosis Cervical, Radiculopathy, Cervical Region

    Hard Cervical Collar Use Following Posterior Cervical Fusion

    • Recruiting
    • Age: 18 years and older
    • Medical device

    Postoperative immobilization with a hard cervical collar following posterior cervical fusion remains common practice despite limited evidence demonstrating improved clinical outcomes.

    Conditions
    Spinal Stenosis Cervical, Radiculopathy, Cervical Region, Posterior Cervical Fusion, Spondylosis, Cervical
    Trial name
    NCT07789288
    Testing
    Hard Cervical Collar
    Where
    2 sites in United States
    Volunteers
    150 people
    Sponsor
    Georgetown University
    Can I take part? NCT07789288

  • Nonsmall Cell Lung Cancer Stage

    SBRT for Ultra-Central NonSmall Cell Lung Cancer

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 1
    • Surgery or procedure

    The goal of this clinical trial is to find out if Five-fraction CyberKnife stereotactic body radiation therapy (SBRT) with real-time Synchrony® motion tracking can treat ultra-central nonsmall cell lung cancer while reducing the…

    Trial name
    STELLAR IIT (NCT07852247)
    Testing
    SBRT
    Where
    United States
    Volunteers
    35 people
    Sponsor
    Georgetown University
    Can I take part? STELLAR IIT

  • Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma

    Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

    • Recruiting
    • Age: 18 years and older
    • Phase 2
    • Injection or infusion
    • Surgery or procedure

    This phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancreatic cancer that can be removed by surgery (resectable) or that is borderline…

    Conditions
    Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8
    Trial name
    NCT06423326
    Testing
    Biopsy, Biospecimen Collection, Cisplatin
    Where
    2 sites in United States
    Volunteers
    36 people
    Sponsor
    Georgetown University
    Can I take part? NCT06423326

  • Cancer, Breast, Age-related Cognitive Decline

    Older Breast Cancer Patients: Risk for Cognitive Decline

    • Recruiting
    • Age: 60 to 105 years
    • Observational study

    The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore change in APE, LM and Cognition domains, measure associations between cognitive decline and QOL, and…

    Conditions
    Cancer, Breast, Age-related Cognitive Decline, Cognitive Decline
    Trial name
    TLC (NCT03451383)
    Where
    United States
    Volunteers
    1,700 people, healthy volunteers welcome
    Sponsor
    Georgetown University
    Can I take part? TLC

  • Parkinson's Disease

    RESvEraTrol in Parkinson's Disease (RESET)

    • Recruiting
    • Age: 55 to 85 years
    • Phase 2
    • Pill or oral medicine

    This is an exploratory phase 2a study to investigate two doses of resveratrol (JotrolTM) vs placebo in individuals diagnosed with Parkinson's Disease (PD).

    Trial name
    RESET (NCT07592767)
    Testing
    Trans-Resveratrol
    Where
    United States
    Volunteers
    30 people
    Sponsor
    Georgetown University
    Can I take part? RESET

  • Visual Field Defect, Stroke

    Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training

    • Recruiting
    • Age: 18 years and older
    • Medical device
    • Lifestyle or therapy programme

    The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual…

    Conditions
    Visual Field Defect, Stroke, Hemianopia, Quadrantanopia
    Trial name
    VIBRANT (NCT07105358)
    Testing
    transcranial random noise stimulation (tRNS), Perceptual learning-based training
    Where
    United States
    Volunteers
    30 people
    Sponsor
    Georgetown University
    Can I take part? VIBRANT

  • Visual Field Defect, Stroke

    Home-based Vision Rehabilitation Guided by Brain Imaging

    • Recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual…

    Conditions
    Visual Field Defect, Stroke, Hemianopia Homonymous, Quadrantanopia
    Trial name
    BRIGHT (NCT07635329)
    Testing
    High-level perceptual learning-based training, Low-level perceptual learning-based training
    Where
    United States
    Volunteers
    100 people
    Sponsor
    Georgetown University
    Can I take part? BRIGHT

Completed, with results posted

All –

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in